Heron Therapeutics
HRTX
69 hedge funds and large institutions have $385M invested in Heron Therapeutics in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 15 closing their positions.
2,065% more call options, than puts
Call options by funds: $18.4M | Put options by funds: $848K
64% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 14
57% more capital invested
Capital invested by funds: $245M → $385M (+$139M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
33% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 15
8% more funds holding
Funds holding: 64 → 69 (+5)
Top Buyers
| 1 |
Allianz Asset Management
Munich,
Germany
|
+$10.8M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$6.43M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$6.1M |
| 4 |
Millennium Management
New York
|
+$4.82M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$3.04M |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$6.7M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$6.32M |
| 3 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$2.98M |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$2.71M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.84M |
HRTX Hedge Fund Activity: Q1 2015 in Review
69 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q1 2015, worth a combined $385M — up 57% from $245M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new HRTX positions and 15 closed out — a net gain of 5 holders — while 23 added to existing stakes and 14 trimmed.
The largest buyer was Allianz Asset Management, opening a new position worth an estimated $10.8M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $6.7M sold.
- 69 institutional investors held Heron Therapeutics (HRTX) as of Q1 2015, up from 64 in Q4 2014.
- Funds reported $385M of Heron Therapeutics stock for Q1 2015, up 57% quarter-over-quarter.
- 20 funds opened new Heron Therapeutics positions in Q1 2015 and 15 closed out, a net change of +5 holders.
- The largest Heron Therapeutics buyer in Q1 2015 was Allianz Asset Management, an estimated $10.8M added.
- The largest Heron Therapeutics seller in Q1 2015 was Perceptive Advisors, an estimated $6.7M sold.
Based on aggregated 13F filings for Q1 2015.